Previous 10 | Next 10 |
home / stock / stz / stz articles
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended waiting another quarter to buy Walgreens Boots Alliance, Inc. (NASD...
On Friday, Constellation Brands (NYSE: STZ) reported its third quarter financials that fell short of expectations as persistently high inflation sl...
Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced on Tuesday that it has entered into subscription agreements with certain institutional ...
The CNN Money Fear and Greed index showed some improvement in overall market sentiment, while the index remained in the "Greed" zone on F...
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow traded up 0.13% to 3...
Around 15% of Americans said they were planning to participate this year in Dry January — a month of abstinence from alcohol — according to a s...
Constellation Brands Inc (NYSE: STZ), an international producer and marketer of beer, wine, and spirits, reported third-quarter FY24 net sales...
Stocks could be headed lower yet again on Friday, with the market off to a rocky start for the year. Technology stocks are getting thrashed amid th...
The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, with the index moving to the "Greed" zone on Thur...
News, Short Squeeze, Breakout and More Instantly...
Constellation Brands Inc. Company Name:
STZ Stock Symbol:
NYSE Market:
Constellation Brands Inc. Website:
2024-07-09 07:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-05 08:15:04 ET UBS analyst issues BUY recommendation for STZ on July 5, 2024 07:02AM ET. The previous analyst recommendation was Buy. STZ was trading at $249.21 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recom...